News
An expert discusses how home administration of oncology drugs in the US faces significant logistical and reimbursement ...
What if you could inject a drug into a "problem area" – like abdominal fat – that could kill off fat cells and reduce fat ...
The opinion is based on positive data from the phase 3 Balance study, which showed a significant reduction of triglycerides ...
6d
Medical Device Network on MSNBD announces wearable injector trial for subcutaneous delivery of biologicsThe prefilled, patient-ready-to-use system is said to support delivery of high-viscosity biologics of up to 50 centipoise.
Subcutaneous injections do not require a port like an IV, eliminating the risk for port-related complications such as infections.
Ocrevus subcutaneous injection was non-inferior to Ocrevus IV infusion as measured by Ocrevus levels in the blood of patients (area under the serum concentration time curve) from day 1 to 12 weeks ...
The FDA has approved nivolumab and hyaluronidase-nvhy for subcutaneous injection in adults with solid tumors in which nivolumab is indicated, according to a press release.Nivolumab and ...
Lonapegsomatropin is a pegylated prodrug of the human growth hormone, somatropin, administered as a subcutaneous injection once-weekly.
A new kind of HIV prevention is making it easier for those at risk to stay protected, thanks to a twice-yearly injection now ...
Subcutaneous: Subcutaneous injections are given at a 45-degree angle, usually in the thigh (for babies under the age of 12 months) or upper-outer triceps area for people over 12 months.
CHICAGO — An oral robotic pill may provide an alternative delivery method to subcutaneous injection for teriparatide and other biologics, according to a speaker at ENDO 2023. In findings from a ...
Roche Holdings AG's (OTC: RHHBY) Phase 3 OCARINA II trial evaluating Ocrevus (ocrelizumab) as a twice-a-year 10-minute subcutaneous injection met its primary and secondary endpoints in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results